Aigen Investment Management LP Invests $368,000 in The Cooper Companies, Inc. $COO

Key Points

• Aigen Investment Management LP has acquired a new position in The Cooper Companies, investing approximately $368,000 for 4,358 shares, as disclosed in an SEC filing.
• The Cooper Companies' stock has experienced positive movement, trading up 2.2% on recent reports, with a current share price around $74.27.
• Analyst sentiment is mixed, with ratings ranging from hold to buy, and a consensus price target of $96.73 reported by MarketBeat.

Aigen Investment Management LP bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 4,358 shares of the medical device company's stock, valued at approximately $368,000.

Several other hedge funds also recently made changes to their positions in COO. Covestor Ltd raised its holdings in shares of Cooper Companies by 35.5% during the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock worth $42,000 after buying an additional 120 shares in the last quarter. Shell Asset Management Co. increased its position in Cooper Companies by 15.5% during the 4th quarter. Shell Asset Management Co. now owns 946 shares of the medical device company's stock worth $87,000 after purchasing an additional 127 shares in the last quarter. UMB Bank n.a. boosted its position in Cooper Companies by 16.7% in the first quarter. UMB Bank n.a. now owns 902 shares of the medical device company's stock valued at $76,000 after buying an additional 129 shares in the last quarter. Axxcess Wealth Management LLC increased its holdings in Cooper Companies by 1.9% in the 1st quarter. Axxcess Wealth Management LLC now owns 7,382 shares of the medical device company's stock worth $623,000 after purchasing an additional 140 shares in the last quarter. Finally, Mitchell & Pahl Private Wealth LLC increased its position in Cooper Companies by 1.8% in the 1st quarter. Mitchell & Pahl Private Wealth LLC now owns 8,675 shares of the medical device company's stock valued at $732,000 after acquiring an additional 157 shares during the period. 24.39% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

COO has been the topic of several analyst reports. Needham & Company LLC upgraded Cooper Companies from a "hold" rating to a "buy" rating and set a $94.00 target price on the stock in a report on Tuesday, June 17th. Wells Fargo & Company dropped their price objective on Cooper Companies from $118.00 to $93.00 and set an "overweight" rating on the stock in a research note on Friday, May 30th. BNP Paribas Exane raised Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 target price for the company in a research note on Tuesday, July 22nd. BNP Paribas upgraded Cooper Companies from a "hold" rating to a "strong-buy" rating in a report on Tuesday, July 22nd. Finally, Mizuho cut their price target on Cooper Companies from $105.00 to $90.00 and set an "outperform" rating on the stock in a report on Wednesday, July 16th. Three analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $96.73.

Cooper Companies Stock Up 1.1%

Shares of COO stock traded up $0.77 on Monday, hitting $74.03. The stock had a trading volume of 475,329 shares, compared to its average volume of 2,147,477. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.10 and a quick ratio of 1.23. The business has a 50 day moving average of $71.92 and a 200 day moving average of $78.84. The Cooper Companies, Inc. has a 12-month low of $65.00 and a 12-month high of $112.38. The stock has a market cap of $14.80 billion, a price-to-earnings ratio of 35.97, a price-to-earnings-growth ratio of 1.79 and a beta of 1.00.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.93 by $0.03. The firm had revenue of $1 billion during the quarter, compared to analyst estimates of $995.12 million. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%. The business's revenue was up 6.3% compared to the same quarter last year. During the same period last year, the firm posted $0.85 EPS. As a group, analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.